The Mito Foundation aims to improve the lives of people affected by mitochondrial disease. They provide support and trusted information, push for better services and treatments, and fund research that endeavours to bring about a cure. 

What is ADOA?

Autosomal Dominant Optic Atrophy (ADOA) is a genetic condition that causes progressive damage to the optic nerves. It typically results in gradual loss of central and colour vision, often beginning in childhood or early adulthood. ADOA is often caused by changes to the OPA1 gene and is considered a type of mitochondrial disease. ADOA is inherited in an autosomal dominant pattern, meaning it can be passed from an affected parent to their child.

Why is this event and project important?

The webinar aims to provide information about ADOA in a way that empowers people affected. The event will include information about the signs and symptoms of ADOA, the role of genetic testing and progress being made in research.